Mark Feitelson - Y Combinator Founder of SFA Therapeutics
Home›Founders›Mark Feitelson
Mark Feitelson, Founder of SFA Therapeutics

Mark Feitelson

Founder at SFA Therapeutics

Mark Feitelson received his Ph.D. in Microbiology/Immunology from UCLA. He began his work with hepatitis B at Stanford University, and was then recruited to the Fox Chase Cancer Center by Dr. Baruch Blumberg (Nobel laureate). In 1991, Dr. Feitelson moved to Thomas Jefferson University, and in 2007, to Temple University as a Professor of Biology. His work has been supported by NIH, industry and foundations. He has more than 150 publications and 180 abstracts. He is also CSO of SFA Therapeutics.

Previously at

Temple University
Temple University
Thomas Jefferson University Hospital
Thomas Jefferson University Hospital
Thomas Jefferson University
Thomas Jefferson University
Fox Chase Cancer Center
Fox Chase Cancer Center
Stanford University
Stanford University
Stanford University School of Medicine
Stanford University School of Medicine
Alumnus of
David Geffen School of Medicine at UCLA
David Geffen School of Medicine at UCLA
University of California, Irvine
University of California, Irvine
Cypress College
Cypress College